Alex Azar, health secretary: Already briefing Biden team on COVID-19 By Tom Howell Jr. - The Washington Times Shares
Pfizer seeking emergency use of its COVID-19 vaccine in U.S. By Lauran Neergaard - Associated Press Shares
What does emergency use of a COVID-19 vaccine mean? By The Associated Press - Associated Press Shares
FDA gives emergency approval for rheumatoid arthritis drug and remdesivir as COVID-19 treatment By Shen Wu Tan - The Washington Times Shares
FDA allows 1st rapid virus test that gives results at home By MATTHEW PERRONE - Associated Press Shares
AP FACT CHECK: Trump’s bogus claims about Biden win, vaccine By HOPE YEN and COLLEEN LONG and LAURAN NEERGAARD - Associated Press Shares
AP FACT CHECK: Trump falsehoods on Biden win, vaccine myths By HOPE YEN and COLLEEN LONG and LAURAN NEERGAARD - Associated Press Shares
Trump, still not conceding defeat, trumpets vaccine progress By ZEKE MILLER and KEVIN FREKING and AAMER MADHANI - Associated Press Shares
Pfizer: Early look shows COVID-19 vaccine is 90% effective By Tom Howell Jr. - The Washington Times Shares
FDA panel urges rejection of experimental Alzheimer’s drug By MARILYNN MARCHIONE and MATTHEW PERRONE - Associated Press Shares
White House nixes updated FDA guidelines on vaccine approval By Zeke Miller and Matthew Perrone - Associated Press Shares
Fed gov’t begins to detail a ‘highly controlled’ vaccine distribution plan By Tom Howell Jr. - The Washington Times Shares
Scarcity of raw material still squeezes N95 mask makers By MARTHA MENDOZA, JULIET LINDERMAN and THOMAS PEIPERT AND IRENA HWANG - Associated Press Shares
Americans fear coronavirus vaccine will be based on politics over safety By Tom Howell Jr. - The Washington Times Shares
Scarcity of key material squeezes medical mask manufacturing By MARTHA MENDOZA, JULIET LINDERMAN and THOMAS PEIPERT and IRENA HWANG - Associated Press Shares
Vaccine by Nov. 3? Halted study explains just how unlikely By LAURAN NEERGAARD - Associated Press Shares
Nine drug CEOs sign safety pledge on COVID-19 vaccine By Tom Howell Jr. - The Washington Times Shares
White House faces skepticism over prospects for a vaccine By LINDA A. JOHNSON and MICHELLE R. SMITH - Associated Press Shares